13-24321282-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178540.5(C1QTNF9):āc.516G>Cā(p.Gln172His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000214 in 1,496,896 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QTNF9 | NM_178540.5 | c.516G>C | p.Gln172His | missense_variant | 4/4 | ENST00000332018.5 | |
C1QTNF9 | NM_001303137.2 | c.516G>C | p.Gln172His | missense_variant | 5/5 | ||
C1QTNF9 | NM_001303138.2 | c.516G>C | p.Gln172His | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QTNF9 | ENST00000332018.5 | c.516G>C | p.Gln172His | missense_variant | 4/4 | 1 | NM_178540.5 | P1 | |
C1QTNF9-AS1 | ENST00000449656.1 | n.73+244C>G | intron_variant, non_coding_transcript_variant | 5 | |||||
C1QTNF9 | ENST00000382071.6 | c.516G>C | p.Gln172His | missense_variant | 4/4 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000134 AC: 16AN: 119078Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.0000389 AC: 7AN: 179758Hom.: 0 AF XY: 0.0000207 AC XY: 2AN XY: 96668
GnomAD4 exome AF: 0.0000116 AC: 16AN: 1377724Hom.: 1 Cov.: 33 AF XY: 0.00000293 AC XY: 2AN XY: 681980
GnomAD4 genome AF: 0.000134 AC: 16AN: 119172Hom.: 0 Cov.: 17 AF XY: 0.000143 AC XY: 8AN XY: 56062
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.516G>C (p.Q172H) alteration is located in exon 4 (coding exon 3) of the C1QTNF9 gene. This alteration results from a G to C substitution at nucleotide position 516, causing the glutamine (Q) at amino acid position 172 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at